Related references
Note: Only part of the references are listed.Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis
Yunxin Liu et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases
Tarun Belwal et al.
FRONTIERS IN PHARMACOLOGY (2020)
Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway
Xiaopeng Zhu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects
Guofei Li et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Active compounds of medicinal plants, mechanism for antioxidant and beneficial effects
Orozco Montes F et al.
PHYTON-INTERNATIONAL JOURNAL OF EXPERIMENTAL BOTANY (2019)
Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders
Maria A. Neag et al.
FRONTIERS IN PHARMACOLOGY (2018)
Gene expression profiling of HepG2 cells after treatment with black tea polyphenols
Jie Zhong et al.
BIOCELL (2018)
Berberine-induced Inactivation of Signal Transducer and Activator of Transcription 5 Signaling Promotes Male-specific Expression of a Bile Acid Uptake Transporter
Pengli Bu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells
H. Ruan et al.
ONCOGENE (2017)
Ginkgolide B protects human umbilical vein endothelial cells against xenobiotic injuries via PXR activation
Tao Zhou et al.
ACTA PHARMACOLOGICA SINICA (2016)
Dihydroartemisinin Restricts Hepatic Stellate Cell Contraction via an FXR-S1PR2-dependent Mechanism
Wenxuan Xu et al.
IUBMB LIFE (2016)
A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine
Shenghua Gu et al.
MOLECULAR BIOSYSTEMS (2015)
Threonine-290 Regulates Nuclear Translocation of the Human Pregnane X Receptor through Its Phosphorylation/Dephosphorylation by Ca2+/Calmodulin-Dependent Protein Kinase II and Protein Phosphatase 1
Junko Sugatani et al.
DRUG METABOLISM AND DISPOSITION (2014)
Prediction of Organic Anion-Transporting Polypeptide 1B1-and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data
Annett Kunze et al.
DRUG METABOLISM AND DISPOSITION (2014)
Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver
Jeff L. Staudinger et al.
DRUG METABOLISM REVIEWS (2013)
Repeated administration of berberine inhibits cytochromes P450 in humans
Ying Guo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
The Role of a Basolateral Transporter in Rosuvastatin Transport and Its Interplay with Apical Breast Cancer Resistance Protein in Polarized Cell Monolayer Systems
Jibin Li et al.
DRUG METABOLISM AND DISPOSITION (2012)
Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia
Nan Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
Colesevelam Added to Combination Therapy With a Statin and Ezetimibe in Patients With Familial Hypercholesterolemia: A 12-Week, Multicenter, Randomized, Double-Blind, Controlled Trial
Roeland Huijgen et al.
CLINICAL THERAPEUTICS (2010)
Liver X Receptor α and Farnesoid X Receptor Are Major Transcriptional Regulators of OATP1B1
Henriette E. Meyer Zu Schwabedissen et al.
HEPATOLOGY (2010)
Anti-Atherogenic Effect of Berberine on LXRα-ABCA1-Dependent Cholesterol Efflux in Macrophages
Tzong-Shyuan Lee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Activation of Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) by Herbal Medicines
Thomas K. H. Chang
AAPS JOURNAL (2009)
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin. receptor expression
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin
Satoshi Kitamura et al.
DRUG METABOLISM AND DISPOSITION (2008)
Combination of simvastatin with berberine improves the lipid-lowering efficacy
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: Implications for interindividual variability in response to drugs
Bradley L. Urquhart et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
Yoshihisa Shitara et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes
Emilie Jigorel et al.
DRUG METABOLISM AND DISPOSITION (2006)
Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study
XC Wu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
The superfamily of organic anion transporting polypeptides
B Hagenbuch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2003)
Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors
PA Mak et al.
JOURNAL OF LIPID RESEARCH (2002)
Cerivastatin and reports of fatal rhabdomyolysis.
JA Staffa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Structure, function and regulation of the ABC1 gene product
G Schmitz et al.
CURRENT OPINION IN LIPIDOLOGY (2001)
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia
HH Knapp et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Safely and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia
ML Wolfe et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Share Paper
